Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial

HAVEL, L., ZEMANOVÁ, M., PEŠEK, M., KOLEK, V., SPÍŠEK, R., BARTŮŇKOVÁ, J., PECEN, Ladislav, KRASNOPOLSKAYA, I., ČERNOVSKÁ, M. Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial. Journal of Clinical Oncology. 2018, 36(15 suppl), 9051-9051. ISSN 0732-183X. E-ISSN 1527-7755. Available: doi: 10.1200/JCO.2018.36.15_suppl.9051